Delivery Order SPE2DB24D8002-SPE2DB25FJMPS
Award Date
10/25/24
Potential Completion Date
10/28/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,399.31, is for the delivery of NURTEC ODT 75 MG TABLET 8S pharmaceutical products. The contract is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,107.36, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through February 28, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $12,238.31 and a period of performance through November 22, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) awarded to Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $2,283.39 and a period of performance through April 3, 2025. Dakota Drug, Inc. is an established federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,506.31 firm fixed-price delivery order is for the provision of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical products,...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S medical supplies, with a ceiling value of $13,362.48 and a period of performance through January 28, 2025. This award is not associated with a set-aside program. Dakota Drug, Inc. also holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $4,121.49, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award is not associated with a larger contract vehicle and does not have a set-aside designation. The contract has an ultimate completion date of January 26, 2024. Dakota Drug, Inc. is a key supplier...
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZHJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,020.34 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a performance period through March 4, 2025. The contract is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $4,403.92, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a broader indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,997.26, is for the delivery of NURTEC ODT 75 MG TABLET 8S and does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001 and valued at $999,999,999.00. This IDC is...